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Mutations in the large gene of clotting factor VIII (FVIII) are the most common events leading to severe human
bleeding disorder. The high proportion of de novo mutations observed in this gene raises the possibility that a
significant proportion of such mutations does not derive from a single germ cell but instead should be attributed
to a germline or somatic mosaic originating from a mutation during early embryogenesis. The present study explores
this hypothesis by using allele-specific PCR to analyze 61 families that included members who had sporadic severe
hemophilia A and known FVIII gene defects. The presence of somatic mosaicisms of varying degrees (0.2%–25%)
could be shown in 8 (13%) of the 61 families and has been confirmed by a mutation-enrichment procedure. All
mosaics were found in families with point mutations (8 [25%] of 32 families). In the subgroup of 8 families with
CpG transitions, the percentage with mosaicism increased to 50% (4 of 8 families). In contrast, no mosaics were
observed in 13 families with small deletions/insertions or in 16 families with intron 22 inversions. Our data suggest
that mosaicism may represent a fairly common event in hemophilia A. As a consequence, risk assessment in genetic
counseling should include consideration of the possibility of somatic mosaicism in families with apparently de novo
mutations, especially families with the subtype of point mutations.
Introduction
Hemophilia A (HEMA [MIM 306700]) is the most
common severe hereditary bleeding disorder in humans,
affecting 1 in 5,000 male newborns. The phenotype is
caused by a defective or absent factor VIII protein, which
leads to varying degrees of hemorrhage. The factor VIII
(FVIII) gene spans 186 kb on chromosome Xq28 and
consists of 26 exons. The types of genetic defects vary
widely. In severe hemophilia A, 40% of all mutations
are caused by the intron 22 inversion (Lakich et al.
1993). Another 30%–35% of severely affected hemo-
philiacs carry point mutations, either of the nonsense or
of the missense type, which are randomly distributed
throughout the gene. A minor fraction of mutations
comprises small deletions/insertions (10%) and large de-
letions (5%) (Becker et al. 1996).
Because of the high mutation rate (2.5–4.2 # 105)
(Strauss 1967; Vogel 1977), ∼50% of families severely
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affected by hemophilia A include only one member with
the disorder, an observation that points to a recent or-
igin (parental or grandparental generation) of the mu-
tation in most affected families. Family studies revealed
that mutations in hemophilia A predominantly origi-
nated in males; however, some deletions occurred more
often in females (Becker et al. 1996). Mutations causing
hemophilia A usually appear to have arisen in germ
cells, thereby leading to heterozygosity or hemizygosity
for the respective mutation in the offspring generation.
However, a de novo mutation may also occur during
early embryogenesis and thus may represent either
germline and/or somatic mosaicism, in which type and
degree of mosaicism are determined by the develop-
mental stage and cell lineage.
The significance of mosaic mutations may be under-
estimated, because they usually remain undetected dur-
ing routine mutation analysis. Overexposed manual-
sequence autoradiographs can detect the mutation only
if it is present in 15% of the cells sampled (Ketterling
et al. 1999), and the detection limit of Southern blot
analysis is 10%–20% (Oldenburg et al. 2000). Special
methods, such as allele-specific PCR, are expected to be
more sensitive and may detect a mutant allele that is
present in as few as 1 of 1,000 samples (Kno¨ll et al.
1996). Somatic and germline mosaics have been doc-
umented for only a few X-linked and autosomal dom-
inant single-gene disorders. In neurofibromatosis type
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1 (Colman et al. 1996), osteogenesis imperfecta (Lund
et al. 1996), and Hunter disease (Froissart et al. 1997),
single cases of mosaicism have been described. More-
systematic studies to assess the frequency of mosaicism
have been reported for retinoblastoma (Sippel et al.
1998), Duchenne muscular dystrophy (Passos-Bueno et
al. 1992; van Essen et al. 1992), and hemophilia B (Ket-
terling et al. 1999), and these studies demonstrate that
a significant proportion (10%–20%) of de novo mu-
tations involve proven mosaicism.
In hemophilia A, only seven patients with mosaicism
have been reported, and the mutations in this group
include three large deletions (Higuchi et al. 1988;
Bro¨cker-Vriends et al. 1990; Levinson et al. 1990), one
small deletion (Casey et al. 1999), one inversion of distal
intron 22 (Oldenburg et al. 2000), and two point mu-
tations ( Levinson et al. 1990; Schwaab et al. 1993).
In order to elucidate the frequency of mosaicism in
hemophilia A, we analyzed 61 families with known type
and origin of FVIII gene mutations for the presence of
mosaic individuals. A total of eight somatic mosaics
were detected, all arising in the patients’ mothers and
grandmothers of families with point mutations. These
findings indicate a significant proportion of mosaicism
in hemophilia A, at least in the subgroup of point mu-
tations, that may confound risk estimation during ge-
netic counseling.
Subjects, Material, and Methods
Families
The present study sample comprises 61 families that
have at least one member with sporadic severe hemo-
philia A and known type and origin of the pathogenic
mutation. Blood or DNA samples were provided by the
following institutions: Department of Experimental He-
matology and Transfusion Medicine, Bonn; Department
of Human Genetics, Mu¨nster, Germany; Department of
Human Genetics, Wu¨rzburg, Germany; INSERM U143,
Hoˆpital Bicetre, Le Kremlin Bicetre, France; Division of
Genomic Medicine, University of Sheffield, Royal Hal-
lamshire Hospital, Sheffield, United Kingdom; and De-
partment of Paediatrics, University Hospital, Malmo¨,
Sweden. All patients gave informed consent, according
to the declaration of Helsinki.
Mutation Analysis of the Factor VIII Gene
Mutation analysis was performed using the Southern
blot technique for the detection of the intron 22 inver-
sion (Lakich et al. 1993) and using the various mutation-
screening methods established in the authors’ respective
laboratories (Lavergne et al. 1992; Becker et al. 1996;
Tavassoli et al. 1998; Williams et al. 1998; Ljung and
Sjorin 1999). Mutations localized by the screening meth-
ods were characterized by sequencing the corresponding
exon.
Allele-Specific PCR and Detection of Fluorescence-
Labeled PCR Fragments
The principle of this method is based on the fact that
a mismatch at the 3′ end of a primer leads to an insuf-
ficient elongation during PCR by the Taq polymerase.
A primer that matches a mutation with its 3′ end and
concomitantly mismatches to the wild-type allele allows
the amplification of the mutated allele but suppresses
amplification of the wild-type allele. Allele discrimina-
tion can be improved by incorporating an additional
mismatching base three bases upstream of the 3′ end of
the primers (Hezard et al. 1997). All reverse primers
were dye labeled, and the PCR products were detected
and sized on a 373A DNA sequencer (ABI).
Allele-specific PCR was performed in a Biometra Trio-
Thermoblock. Amplifications were performed using 200
ng of genomic DNA, 20 pmol of allele-specific prim-
er (table 1), 20 pmol of dye-labeled reverse primer
(Schwaab et al. 1997), 50 mM of each of the four types
of dNTP, and 2.5 U of AmpliTaq-Gold DNA polymerase
(PE Applied Biosystems) in a total volume of 50 ml. The
PCR program was set to initial denaturation at 94C for
9 min, followed by 32 cycles of amplification with 45 s
of denaturation at 94C, 45 s of annealing at 55C, and
90 s of elongation at 72C. If allele discrimination was
insufficient under these conditions, the annealing tem-
perature was raised in steps of 2C to optimize the per-
formance of the allele-specific PCR; 1 ml of the PCR
product was mixed with 1.5 ml of formamide, 0.5 ml
LS500 size standard (serac R. Hofmann GmbH), and
0.2 ml of gel-loading buffer. DNA fragments were sep-
arated on a 373A DNA sequencer (ABI) using a 6%
denaturing polyacrylamide gel. Data were analyzed by
GENESCAN 672 software (ABI).
Intron 22–Inversion PCR
The PCR for detection of the intron 22 inversion
was performed as described by Liu et al. (1998), with
the following slight modifications: PCR-amplification
started with 100 ng of DNA, and the amplified frag-
ments were separated on 0.8% agarose for 24 h. PCR
fragments were detected by Southern blot analysis of the
agarose gel, using standard conditions. A digoxigenin-
labeled probe (HA-Int22: 5′-digoxigenin-GAGAAGGC-
GCCCAGG) was used for hybridization, and DNA frag-
ments were visualized according to the protocol of the
manufacturer (Roche).
Mutation Enrichment and DNA Sequencing
To obtain evidence of somatic mosaicism, a modified
method of the protocol described by Kno¨ll et al. (1996)
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Table 1
Primers for Allele-Specific PCR
Family
Allele-Specific
Primer Sequence (5′–3′)
LU3 GCCAAGGCCACCCTGGATTGA
LU¨P2 CCTACCATCCAGGCTGAAGA
LA30 CCATCCAGGCTGAGGTTTGTC
LA27 CTATAGGAGCTGAATATGTTT
ROP1 GACCTTGGACAGTTTCTTCC
TRP1 ATTACATTGCTGCTGATGG
LU6 TGAAGCTATTCAGCATGATTG
JO7 CATATAACATCTACCCTCTCA
LA37 ATATGTAATTAACAGATAATATA
LA6 GTATTTGATGAGAACCGATGG
LA15 CCATTGTTTTTGCAGGCACCG
JO1 GTGATTTGTTGATGCTCTAGT
LA40 GTGATTTGTTGATGCTCTAGT
EGL1 GAGAATAGTCCATCAGTGTA
JO5 CTTGCCAGAATCAGCAAGGAGA
PE1 CAGATACCAAAAGAAGAATA
PE3 CAGATACCAAAAGAAGAATA
EGL2 AGACAAGTGACAGTACAAGG
PE4 GAGTGTCAGACTCCCCTAGT
JO8 GGCAAAGGACAGTGGGCTCT
JO19 TTAACCCTCCAATTATTGGTT
JO10 CGATACATCCGTTTGCATCG
LA28 ATAGCATTCGCAGCACTCCTT
LA38 CAGCACTCTTCGCATGGACTC
LA5 CCTGGTCTCCTTCAAAAGGTT
LA10 CCTGGTCTCCTTCAAAAGGTT
PE2 AGCATGTATGTGAAGGATTG
LA14 GGTGAACTCTCTAGACCCTCT
SCP1 TTACTGACTCGCTACCTACT
RHP1 TTACTGACTCGCTACCTACT
LA29 TTACTGACTCGCTACCTACC
JO9 CTCAGTCGTGTACAAAAAGTT
LA41 GTGTACAAAAAGACTCTGTAG
LU9 GGGAAGTTGGAGACACACCGA
LA18 GTTGGAGACACACTGTTGTGG
LA39 CTGTAGATCAAAGAGGAAACAG
LU5 ACAATTCCATCAGACAATCTT
LU7 CACACAATCAAGAAAAAATAT
MAB1 CACACAATCAAGAAAAAATAT
LA11 CACACAATCAAGAAAAAATAT
LA16 TCCATCTATTAGACCTATTTC
LOP1 GTGTTCACTGTACGAAAATAG
JO4 TGCCATTCTGAAAAAAGTGT
Table 2
Primers for Incorporation of Artificial Restriction Sites and
Sequencing
Family, Restriction
Endonuclease, and
Primer Primer Sequence
JO1, NruIa:
E14JO1ARS/F AGTGATTTGTTGATGCTCTCG
Ex14-2R ATGGAGCTGTGGCCTGAAGTG
M13-Ex14-2R2 M13-ACTGTCTATTGCTCCAGG
JO7, BsiWIa:
E10JO7ARS/F CCATATAACATCTACCCGTAC
Ex10R GCTATAAACGAGGGAATATTTAC
M13-Ex10R M13-CGAGGGAATATTTACCTTTTG
JO10, MunIb:
E23JO10ARS GCTGCGAATGCTATAATCAATT
Ex23F ACTCTGTATTCACTTTCCATG
M13-Ex23F M13-GCTAATCTCTCCATACAG
RHP1, BstBIa:
M13-Ex26F M13-TTGTCCTGTCAGACAACC
Ex26R TTAGCACAAAGGTAGAAGGC
LA3, AvaIIa:
E16LA3ARS GTTTTTTCTAGGTTCTGGTC
Ex16F TTGTCGTTATTGTTCTACAGG
M13-Ex16F M13-CAGGTAACTTTCAGAAATCAG
LA14, AgeIa:
E26LA14ARS TCGAAGGTAGCGAGTCAGTACC
Ex26F AGCGTCTGTGCTTTGCAGTG
M13-Ex26F M13-TTGTCCTGTCAGACAACC
LA28, BstBIa:
E23LA28ARS ATCACAGCCCATCAACTCCATTC
Ex23F ACTCTGTATTCACTTTCCATG
M13-Ex23F M13-GCTAATCTCTCCATACAG
LA15, MunIb
E13LA15ARS CAAACTATCAAAAACATAGCAAT
Ex13FB GGAAGATATAATATCTCTTCC
M13-Ex13FB M13-GGGAATAAGATAATGGGC
NOTE.—The M13-sequence is TGTAAAACGACGGCCAGT.
a Supplied by New England Biolabs.
b Supplied by Gibco BRL Life Technologies.
was established for the enrichment of the mutated FVIII
allele in the DNA samples. In a first step, an artificial
restriction site was created with specially designed prim-
ers. In each case, the 3′ end of the primers flanking the
mutation and parts of the following target sequence cre-
ate a restriction motif that arises only in the wild-type
allele. Subsequent digestion with the appropriate restric-
tion endonuclease (table 2) and reamplification resulted
in an enrichment of the mutated allele. Because restric-
tion endonucleases do not cleave 100% of their tem-
plate, the procedure had to be repeated twice to ensure
the enrichment of the uncleaved PCR product that cor-
responded to the mutant allele.
PCR was performed on a Biometra Trio-Thermoblock
with 1 ml of the initially amplified exon PCR, 100 mM
of each of the four types of dNTP, 20 pmol of each
primer (table 2), and 1.5 U of AmpliTaq-Gold DNA
polymerase (PE Applied Biosystems) in a total volume
of 50 ml. PCR parameters were set to initial denaturation
at 94C for 9 min, 32 cycles of amplification with 30 s
of denaturation at 94C, 30 s of annealing at 55C, and
45 s of elongation at 72C. Subsequently, 10 ml of the
resultant PCR product was digested with 10 U of the
appropriate restriction enzyme (table 2), according to
the manufacturer’s protocol. PCR amplification with
primers creating the respective restriction site and sub-
sequent digestion was repeated three times. After the
final restriction reaction, 1 ml of the assay solution was
amplified with 5 pmol of seminested M13-primers, 50
pmol of the appropriate primers (table 2), 50 mM of
each dNTP, and 1.5 U of AmpliTaq-Gold DNA poly-
merase (PE Applied Biosystems) in a total volume of 50
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ml. PCR reaction was carried out on a Biometra Trio-
Thermoblock and included initial denaturation at 94C
for 9 min, 32 cycles of amplification with 45 s of de-
naturation at 94C, 45 s of annealing at 50C, and 90
s of elongation at 72C. Before sequencing, the product
was cleaned by using the Qiagen PCR Purification Kit,
according to the manufacturer’s protocol. Sequencing
was performed on an MJ Research PTC-200 thermo-
cycler with the Dye Primer Cycle Sequencing Ready Re-
action Kit (PE Applied Biosystems), according to the
manufacturer’s protocol. Sequence reactions were sep-
arated on a 373A DNA sequencer (ABI), using a 7%
denaturing polyacrylamide gel. Data were analyzed by
the 373A data analysis program (ABI).
Results
Families
Screening for somatic mosaicism was performed in a
total of 61 families that included members who had
sporadic severe hemophilia A; 32 families had point mu-
tations, 13 families had small deletions or insertions, and
16 families had the intron 22 inversions (table 3table
3).
DNA or blood samples were provided by five centers
from Germany (24 families), France (23 families), Swe-
den (9 families), and the United Kingdom (5 families)
(see Subjects, Material, and Methods). The families ful-
filled the following criteria: (1) presence of apparently
sporadic hemophilia, (2) successful characterization of
the mutation, (3) availability of blood or DNA samples
from the parental and grandparental generation, and (4)
determination of the mutation origin by mutation anal-
ysis and haplotyping of the patients’ mothers and ma-
ternal grandparents. The origin of the de novo mutation
was assigned to the patient’s mother in 34 families and
was assigned to the father in a single family with a female
index patient. In another family with a female index
patient, the mutation was assigned to one of the patient’s
parents (although it was unclear whether it originated
in the mother or the father); in 10 families it was assigned
to the maternal grandmother, in 14 families to the ma-
ternal grandfather, and in 1 family to the maternal great-
grandfather (table 4).
Detection of Somatic Mosaics
Leukocyte DNA from family members who were iden-
tified as the origin of a de novo mutation by routine
mutation analysis and haplotyping were investigated by
a sensitive allele-specific PCR for the presence of the
sequence alteration. The intron 22 inversion was tested
by a long-range PCR (Liu et al. 1998). Evidence of so-
matic mosaicism was found in 8 (13%) of the 61 families
with hemophilia A, and the proportion of the mutated
allele was 0.2%–25% (figure 1). Each somatic mosaic
was confirmed by control experiments that included en-
richment and sequence analysis of the mutated alleles.
All mosaics were detected in families that had point
mutations, which suggests a 25% mosaicism rate in fam-
ilies with this type of mutation. In the subgroup of C:
G to T:A transitions at a CpG dinucleotide, 50% (4 of
8 families) had evidence of somatic mosaicism. No ev-
idence of mosaicism was obtained in any of the other
mutation types, which may result partly from the low
numbers of families and partly from differences in the
sensitivity of the methods applied. Although the sensi-
tivity of the allele-specific PCR for point mutations was
as great as 0.1% in a wild-type background, it decreased
to 2%–5% for small deletions/insertions. The sensitivity
of the long-range intron 22 inversion PCR was ∼5%.
Dilution experiments with the corresponding DNAs of
the probands were carried out as positive controls for
the PCR performance and for the estimation of the
amount of the mutation in the tested individuals. Inter-
estingly, all somatic mosaicisms emerged in women (five
patient’s mothers and three patient’s grandmothers), al-
though the mutation origin could be assigned to men in
16 (28%) families (table 4).
Detailed descriptions of representative mosaics are
given in figures 2, 3, and 4. The index patient of family
JO1 had a severe hemophilia A phenotype that was
caused by a CpG transition (2440CrT) in exon 14 lead-
ing to a stop codon (table 3). The patient’s mother was
shown, by sequence analysis, to be a noncarrier of the
mutation. Allele-specific PCR clearly detected the mu-
tant allele in the patient’s mother at a proportion that
corresponded to a 1:200 dilution of the patient’s DNA
(fig. 2A). Enrichment and sequence analysis of the mu-
tated allele clearly demonstrated its presence in the
patient’s mother (fig. 2B). The maximal sensitivity of
the allele-specific PCR for the 2440CrT mutation was
shown to be 11:500, corresponding to a sensitivity of
!0.2%.
In family LA14, the index patient had severe hemo-
philia A as a result of a CpG transition (6956CrT) in
exon 26 leading to the missense mutation Pro2300Leu
(table 3). His mother and aunt were carriers of the mu-
tation. The affected X chromosome was inherited by the
grandmother, who did not show the mutation when
tested by sequence analysis. Allele-specific PCR revealed
that the mutated allele was present in the patient’s grand-
mother at a proportion of 5%, corresponding to a 1:20
dilution of the patient’s DNA (fig. 3A). Enrichment of
the mutated allele clearly showed the presence of the
mutation in the grandmother’s leukocyte DNA (fig. 3B).
The sensitivity of the allele-specific PCR for the
6956CrT mutation was shown to be 11:200 or !0.5%.
When the proportion of mutated alleles is 120% (fam-
ilies RHP1 and LA3, fig. 1), the allele-specific PCR could
Table 3
Families, Mutations, and Origin of Mutation
Mutation Type and
Patient Number Family Exon Mutation
Nucleotide
Position Type of Mutationa
Mutation
Origin
Point mutations:
1 LU3 2 266GrA Gly70Asp Non-CpG transition M
2 LU¨P2 3 296TrA Val80Asp Transversion MGM
3 LA30 3 301GrC Asp82His Transversion MGF
4 LA27 4 403GrT Asp116Tyr Transversion M
5 ROP1 7 980TrC Leu308Pro Non-CpG transition MGM
6 TRP1 8 1226ArG Glu390Gly Non-CpG transition M
7 LU6 9 1394CrG Ser446Stop Transversion M
8 JO7 10 1492GrA Gly479Arg CpG transition M
9 LA37 12 1760CrA Ser568Stop Transversion M
10 LA6 12 1809CrG Ser584Arg Transversion MGM
11 LA15 13 1909ArG Asn618Asp Non-CpG transition MGM
12 JO1 14 2440CrT Arg795Stop CpG transition M
13 LA40 14 2440CrT Arg795Stop CpG transition M
14 EGL1 14 3143GrA Trp1029Stop Non-CpG transition M
15 JO5 14 3381GrA Trp1108Stop Non-CpG transition M
16 PE1 14 4796GrA Trp1580Stop Non-CpG transition M
17 PE3 14 4796GrA Trp1508Stop Non-CpG transition MGM
18b LA3 16 5452GrT Gly1799Stop Transversion M
19 EGL2 17 5681ArG Glu1875Gly Non-CpG transition M
20 PE4 20 6134GrT Gly2026Val Transversion MGF
21 JO8 21 6200CrT Pro2048Leu Non-CpG transition M
22 JO19 23 6496CrT Arg2147Stop CpG transition MGF
23 JO10 23 6515CrG Pro2153Arg Transversion M
24 LA28 23 6544CrT Arg2163Cys CpG transition MGM
25 LA38 23 6554TrC Leu2166Ser Non-CpG transition M
26 LA5 24 6682CrT Arg2209Stop CpG transition M
27 LA10 24 6682CrT Arg2209Stop CpG transition M
28 PE2 25 6836TrG Phe2260Cys Transversion MGF
29 LA14 26 6956CrT Pro2300Leu CpG transition MGM
30 SCP1 26 6977GrT Arg2307Leu Transversion MGF
31 RHP1 26 6977GrT Arg2307Leu Transversion M
32 LA29 26 6977GrC Arg2307Pro Transversion M
Small deletions
and insertions:
33 JO9 2 202-207 delACTCTG Thr49 In frame M
34 LA41 2 209-212 delTTGT Cys51 Frameshift M
35 LU9 9 1441 ins-A Trp462 Frameshift MGM
36 LA18 9 1443 ins-TG Trp462 Frameshift MGF
37c LA39 11 1750 delC Gln565 Frameshift M/F
38b REP1 13 1941-1944 delAGTT Ser628 Frameshift M
39 LU5 14 2739 ins-T Trp894 Frameshift M
40 LU7 14 3637 delA Lys1194 Frameshift M
41 MAB1 14 3637 delA Lys1194 Frameshift M
42 LA11 14 3637 delA Lys1194 Frameshift M
43 LA16 14 42644265 delTA Tyr1403 Frameshift M
44 LOP1 18 5961 delA Lys1968 Frameshift M
45c JO4 25 68766877 delCT Leu273 Frameshift F
Inversions:
46 BII1 Distal MGF
47 JO11 Proximal MGF
48 JO17 Distal MGF
49 JO18 Proximal MGGF
50 LA13 Distal MGF
51 LA17 Distal MGM
52 LA21 Distal M
53 LA31 Proximal MGF
54 LA32 Proximal MGF
(continued)
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Table 3 (continued)
Mutation Type and
Patient Number Family Exon Mutation
Nucleotide
Position Type of Mutationa
Mutation
Origin
56 LU2 Distal M
57 LU4 Distal M
58 LU8 Distal MGM
59 OSI1 Distal M
60 PE5 Distal MGF
61 WEI1 Distal MGF
NOTE.—Data for mosaic individuals are underlined.
a M p mother; F p father; MGM p maternal grandmother; MGF p maternal grandfather; MGGF p maternal great
grandfather.
b Other methods were used for examination.
c Female with hemophilia A.
not distinguish between mosaicism and normal carrier
status. However, at this degree of mosaicism, classical
sequence analysis indicated the presence of mosaicism,
as was the case for families LA3 and RHP1. The se-
quence autoradiograph of the patient’s mother in family
LA3 is shown in figure 4A. On the basis of the densities
of the corresponding signals, the proportion of the mu-
tated allele was estimated to be ∼20%. Notably, the
mutated allele was suppressed when sequenced on an
ABI system (fig. 4B). The only indirect sign for the pres-
ence of mosaicism was a lower peak of the correspond-
ing nucleotide. Mutation enrichment clearly showed the
presence of the mutated allele (fig. 4C).
In the present study, allele-specific PCR proved to be
a sensitive method for the detection of mosaics. The
proportion of mosaic cells was estimated by a semi-
quantitative approach of diluting the DNA of the cor-
responding index patients. The degree of dilution that
showed a strength of the allele-specific PCR product sim-
ilar to that of the mosaic individual was taken as a mea-
sure of the proportion of mosaic cells. The results of the
semiquantitative estimate by allele-specific PCR were
supported by manual sequencing autoradiographs from
six of the eight families, with varying degrees of mo-
saicism (0.2%–25%) (fig. 5). The sensitivity of two- to
threefold overexposed autoradiographs corresponds to
a detection limit of 5% for the proportion of mosaic
cells, when compared with the allele-specific PCR.
Higher proportions of mosaic cells showed an increased
density of the signal of the mutated allele, whereas no
signal of the mutated allele could be shown in the auto-
radiographs for the mosaicisms of 2% and lower de-
grees. Thus, the data obtained by overexposed manual
sequencing autoradiographs correspond to the results
from the allele-specific PCR. However, the values given
by the allele-specific PCR should not be regarded as ex-
act numbers but, because of the limitations and semi-
quantitative approach of allele-specific PCR, as an es-
timate of the order of mosaic cells.
Discussion
Frequency of Mosaicism in Hemophilia A
In the present study a systematic search for mosaicism
was performed in 61 families with sporadic hemophilia
A. The search revealed 8 (13%) mutations that origi-
nated as somatic mosaicism. This high number was not
anticipated, because, in spite of extensive mutation anal-
ysis (Antonarakis et al. 1995; Kemball-Cook et al.
1998), only seven mosaics have been reported (Higuchi
et al. 1988; Bro¨ker-Vriends et al. 1990; Levinson et al
1990; Schwaab et al. 1993; Casey et al. 1999; Oldenburg
et al. 2000). Studies that systematically addressed the
question of mosaicism in other hereditary diseases re-
ported proportions of 10%–20% mosaicism in retino-
blastoma (Sippel et al. 1998), Duchenne muscular dys-
trophy (Passos-Bueno et al. 1992; van Essen et al. 1992),
tuberosis sclerosis complex (Verhoef et al. 1999), and
hemophilia B (Ketterling et al. 1999). Thus, somatic mo-
saicism may represent a fairly common event in human
hereditary diseases.
Influence of the Mutation Type
In our study, all mosaics were detected in families with
point mutations. This finding could be the result of var-
ying sensitivities of the methods used to detect mosaicism
but may also indicate that mosaicism arises preferentially
with certain types of mutations. Point mutations or small
deletions or insertions are thought to originate during
mitotic cell divisions and therefore may lead to somatic
mosaicism during early embryogenesis. Somatic mosai-
cism in these two mutation types, as well as in large
deletions, had been anecdotally reported in families with
hemophilia A (Higuchi et al. 1988; Bro¨ker-Vriends et al.
1990; Levinson et al. 1990; Schwaab et al. 1993; Casey
et al. 1999). Except for the mosaic of a small deletion
detected recently by sequencing (Casey et al. 1999), all
mosaics reported elsewhere were found by Southern blot
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Table 4
Origin of FVIII Mutation Types and Allocation of the Somatic Mosaics
VARIABLE
POINT MUTATIONS
SMALL
DELETIONS/
INSERTIONS
INTRON 22
INVERSION OVERALLAll
CpG
Transitions
Non-CpG
Transitions Transversions
Mutation 32 8 11 13 13 16 61
Mosaic 8 4 1 3 … … …
Mutation origin:
M 20 (5) 5 (2) 8 7 (3) 9 5 34
F … … … … 1 … 1
M/F … … … … 1 … 1
MGM 7 (3) 2 (2) 3 (1) 2 1 2 10
MGF 5 1 4 1 8 14
MGGF … … … … … 1 1
% Mosaics 25 50 9 23 … … 13
NOTE.—Numbers of mosaic subjects are shown in parentheses.
analysis, the main tool for mutation detection in the late
1980s. Three of these mosaics were large deletions,
which may reflect the fact that Southern blot analysis
was mainly applied to the study of this mutation type
and of point mutations that affect TaqI restriction sites.
In the present study, no families with large deletions were
included, probably because Southern blot analysis has
became less popular for the detection of large deletions
in females at risk of carrying the mutation.
The intron 22 inversion, which is caused by intra-
chromosomal recombination among the homologous
regions of intron 22 (Lakich et al. 1993), is thought to
be almost exclusively of meiotic origin, arising predom-
inantly in male germ cells (Rossiter et al. 1994; Becker
et al. 1996). This pathogenic mechanism would argue
against a somatic origin of an intron 22 inversion during
early embryogenesis; however, one instance of mosai-
cism with this mutation type has recently been observed
(Oldenburg et al. 2000).
In other disorders that have been systematically an-
alyzed, somatic mosaicism was frequently found in sub-
jects with large deletions (Passos-Bueno et al. 1992; van
Essen et al. 1992) and point mutations (Ketterling et al.
1999). Therefore, a considerable proportion of somatic
mosaics might be expected for most mutation types.
In the subgroup of CpG transitions, four of eight fam-
ilies showed evidence of mosaicism. This finding suggests
that CpG sites may be especially prone to mosaic mu-
tations. Recently, it was reported that human mature
germ cells show a high level of methylation (El-Maarri
et al. 1998). Studies of mouse embryos revealed a global
demethylation of DNA after the formation of the zygote
and during the first cell divisions, which lead to the early
blastocyst stage (Buehr 1997; Drost and Lee 1998). One
possible mechanism of the global demethylation is the
excision of the 5-methylated cytosine nucleotide. The
large number of resulting single-strand breaks may over-
whelm the capacity of downstream repair enzymes and
subsequently lead to the manifestation of mutations at
CpG sites during early embryogenesis (Chu and Mayne
1996; Schmutte and Jones 1998). This hypothesis is at
variance with a study by Ketterling et al. (1999) of fam-
ilies with hemophilia B, which found no somatic mo-
saicism for transitions at CpG sites but, instead, found
four somatic mosaics for CrT transitions at non-CpG
dinucleotides. However, two of these four somatic mo-
saics occurred at CpNpG trinucleotides. This motif is
also known to become methylated in mammalian cells
(Clark et al. 1995). Nevertheless, the number of reported
somatic mosaics is still too small to allow us to draw
any final conclusion about this aspect of its genesis.
Female and Male Origin of Somatic Mosaicism
All somatic mosaicisms in our study were observed in
females. This finding may be the result of a selection
bias among our families. In only 4 (12.5%) of 32 families
with point mutations, the genetic defect originated in
males; however, it was derived from females in 28
(87.5%) families. On the basis of studies that showed a
5:1 male:female ratio for de novo point mutations in
hemophilia A (Becker et al. 1996), the opposite pro-
portions of mutation origins would be expected. Selec-
tion bias probably occurs because blood samples are
more likely to be available from patients’ mothers than
from the patients’ grandparents. Although the difference
is not statistically significant, it is of note that somatic
mosaicism was found in 8 of 28 females but in 0 of 5
males with a de novo point mutation. A less frequent
occurrence of mosaicism in males would agree with the
hypothesis that the higher mutation rate among males
is mainly the result of ongoing cell divisions during male
spermatogenesis, which results in a 15–20-fold higher
number of cell divisions in the male than in the female
germline before fertilization of an oocyte (Vogel and Mo-
tulsky 1986). On the basis of this assumption, the pro-
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Figure 1 Pedigrees of the eight families in which a mosaicism was detected. Blackened symbols indicate the patients with hemophilia;
white circles with dots show carriers of the mutation. Those carriers representing mosaic individuals are indicated by the percentage number
that corresponds to the proportion of the mutated allele. Values for factor VIII:C and vWF:Ag are shown for those mosaic individuals in whom
the information was available. The question mark in family LA28 indicates that it is unknown whether the twins are of monozygotic or dizygotic
origin.
portion of mosaicism originating in males is expected to
be the inverse of the male:female ratio of mutation rates,
resulting in a proportion of mosaicism that is approxi-
mately fivefold lower in males than in females.
Influence of the Method Applied
In the present study we used an allele-specific PCR–
based attempt for point mutations and small deletions/
insertions. For each mutation the sensitivity of the
method was determined by dilution experiments with
DNA from the index patient. Comparison of the signal
intensity of the carrier of the mosaic with those of var-
ious dilutions of the patient’s DNA allowed a semi-
quantitative assessment of the degree of mosaicism. For
point mutations, this approach allowed the detection of
0.1%–0.2% of mutated alleles against a wild-type back-
ground, which represents a ratio of 1:500 to 1:1000,
which is similar to the sensitivity reported by Kno¨ll et
al. (1996) for allele-specific PCR. The presence of the
mutated allele was confirmed by mutation-enrichment
experiments, as indicated in the Subjects, Material, and
Methods section. Although this attempt was highly ef-
ficient at very low degrees of mosaicism, it failed to dis-
criminate between mosaicism and carrier status when
the proportion of mutated alleles was 120%. When the
percentage of mutated alleles is high, the conventional
methods (Southern blot analysis and sequencing) are
likely to detect the presence of mosaicism (fig. 3). The
results obtained by allele-specific PCR were supported
by overexposed manual sequencing autoradiographs
(fig. 5), which detected the mutant allele at proportions
of 5%.
The sensitivity of allele-specific PCR decreased by at
least one order of magnitude for small deletions/inser-
tions. Here, the sensitivity was, at best, at 2% of mutated
alleles in a wild-type background. It even decreased to
5% when the small deletion/insertion was located within
a poly-A stretch (e.g., codons 1192-1194) that is known
to represent a mutation hotspot in hemophilia A. Also,
the long-range PCR for testing the presence of an intron
22 inversion showed a detection limit of ∼5% of mutant
alleles.
When we consider the limited sensitivities of the meth-
ods applied for the detection of mosaicism in at least
some of the mutation types, together with the fact that
mosaicism that affects nearly 50% of the alleles cannot
Figure 3 A, Graph of results of electrophoresis of the allele-
specific PCR of the index patient and the mosaic individual of family
LA14. The upper four traces show the strength of the mutated allele
in the index patient for different dilutions of the allele-specific PCR
product. The mutation can be clearly detected in the trace of the 1:
200 dilution (trace 3). The mosaic individual (trace 5) showed a
strength of the allele-specific PCR product comparable to a 1:20 di-
lution (trace 2), thus corresponding to a proportion of 5% of the
mutated allele. The last trace represents a negative control. B, Nucle-
otide sequence after mutation enrichment. Results clearly indicate the
presence of the mutated allele.
Figure 2 A, Graph of results of electrophoresis of the allele-
specific PCR of the index patient and the mosaic individual of family
JO1. The upper three traces show the strength of the mutated allele
in the index patient for different dilutions of the allele-specific PCR
product. The mutation can be clearly detected in the trace of the 1:
500 dilution. The mosaic individual (trace 4) showed a strength of the
allele-specific PCR product comparable to a 1:200 dilution (trace 2),
thus corresponding to a proportion of 0.5% of the mutated allele. The
last two traces represent negative control samples. B, Nucleotide se-
quence of the reverse strand after mutation enrichment. Results clearly
indicate the presence of the mutated allele.
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Figure 4 A, Autoradiograph of the DNA sequence of the mosaic
individual of family LA3. DNA sequences of both strands are shown
(left panel shows forward sequences; right panel shows reverse se-
quences). Arrows indicate the mosaic mutation in the mother of the
patient (left lane) in comparison with a wild-type control (right lane).
B, the sequence traces of the mutated allele before mutation enrich-
ment. C, the sequence traces of the mutated allele after mutation en-
richment. Although the mutated nucleotide is not visible in B, it could
be clearly identified in C, thus demonstrating that (1) standard au-
tomated sequencing analysis is not able to reveal the presence of a
mosaicism and (2) that it is less sensitive than the classic radioactive
sequencing protocol.
Figure 5 Overexposed manual sequencing autoradiographs for
six families, with the percentage of the mutated alleles (obtained by
allele-specific PCR ) given in parentheses. From each family, the au-
toradiograph of the patient (P), a healthy control individual (K), and
the mosaic individual (M) are shown. Black arrows indicate the mu-
tated alleles, and white arrows indicate and the healthy alleles. Au-
toradiographs were exposed for 3–4 d. Although a strong signal for
the mutated allele is found in family RHP1, only faint signals are
shown in families JO7 and JO10. No signals could be seen in families
LA28, JO1, or LA15, which indicated a lower detection limit of 5%
of the mutated allele when manual sequencing was performed.
be distinguished from carrier status, it seems likely that
some of the somatic mosaics remain undetected and that
the true proportion of mosaicism will be even higher
than the 13% found in our study.
Ascertainment Bias
As already mentioned, male mutation origin is under-
represented in our cohort of families because of the dif-
ficulties of assessing blood samples from the patients’
grandparents. Also, the distribution of mutation types
is not representative of severe hemophilia A. Becker et
al. (1996) found that 37.5% of patients had intron 22
inversions and 32% had point mutations, whereas in
our cohort the intron 22 inversions accounted for 26.2%
of the index patients, and point mutations accounted for
52.5%. The different mutation profiles may result from
the multicenter character of this study. Both types of
bias—the underrepresentation of male mutation origin
and of the intron 22 inversion—would lead to an over-
estimation of the proportion of mosaic individuals,
because, in both male mutation origin and intron 22
inversion, a higher proportion of germ cell mutations
would be expected.
Somatic Mosaicism and Implications for Risk
Assessment in Genetic Counseling
In the mouse model, the blastocyst stage consists of
the inner cell mass (ICM) and the trophoblast (fig. 6).
The ICM develops into the primary ectoderm and the
primary endoderm. Only the primary ectoderm (epi-
blast) that generates the embryonic body retains the
capacity to form germ cells (Wylie 1999). An early
mutation (before the blastocyst stage) may appear as a
complete mutant because, at this stage, very few cells
are destined to form the embryonic body, thus masking
a somatic origin of the mutation. Mutations occurring
at a later stage of embryogenesis will appear as somatic
mosaics, with the proportion of mutated alleles depend-
ing on the time and location of the mutational event.
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Figure 6 Detailed description of the developmental processes during early embryogenesis in mammals, on a time axis.
A question of special interest in the study of somatic
mosaicism is the proportion of germ cells that are af-
fected by the mutation. According to Soriano and Jaen-
isch (1986), in mice at least three cells, which are allo-
cated before the onset of the somatic cell lineages, are
thought to give rise to the germline. In humans, Cohn
et al. (1990) estimated—by comparing different pro-
portions of mosaic mutations in sperm and tissue DNA
in a family affected with osteogenesis imperfecta—that
four progenitor cells make up the germline. The idea
that the germline has a limited number of progenitor
cells would have a great impact on genetic counseling.
Thus, in a somatic mosaic individual, the number of
mutant alleles in the germ cells will not decrease below
a certain proportion. This lower threshold would be one
in eight, when eight monozygotic cells originating from
the four putative progenitor cells during the first meiotic
cell division are considered. In our study, a considerable
recurrence risk is indicated by two of the eight somatic
mosaics in whom the mutation had been transmitted to
two descendants, in spite of low proportions of the mu-
tated allele (4% and 10%, respectively) in leukocyte
DNA (families LA14 and JO7; fig. 1). Family LA28
would represent a third family if the twins were dizy-
gotic; however, the status is not known to the authors).
These findings suggest a higher proportion of the defec-
tive allele in the germ cells of the mosaic individuals. A
high proportion of mutant alleles in germ cells is also
suggested by studies of Duchenne muscular dystrophy,
which estimate a risk of 7%–11% of transmitting the
mutant allele to the first generation of offspring, al-
though the mutation was not detected in the leukocyte
DNA of the mosaic individual (Bakker et al. 1989; van
Essen et al. 1992).
The occurrence of somatic and germ cell mosaicism
represents a matter of concern to the genetic counselor,
because it causes uncertainty about the recurrence risk
in parents who appear to be noncarriers. Even direct
determination of the underlying genetic defect will not
detect mosaicism during routine diagnostic procedures.
Because past reports of somatic mosaicism in hemophilia
A were essentially anecdotal, most genetic counselors
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may have neglected this problem. Our findings clearly
demonstrate the need to consider the potential risk of
somatic mosaicism in families with sporadic hemophilia
A, especially in those with point mutations.
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